Quantitative assessment of lingual strength in late‐onset Pompe disease

Introduction: Skeletal muscle is common in late‐onset Pompe disease (LOPD). Recent data implicate common bulbar muscle involvement (i.e., the tongue). Methods: We used quantitative assessment of lingual strength to retrospectively determine the frequency and severity of lingual weakness in LOPD. We additionally examined associations between lingual strength and the presence or absence of dysarthria, and dysarthria severity. Results: Quantitative assessment revealed lingual weakness to be present in 80% of the sample. In the 24 affected patients, severity was mild in 29%, moderate in 29%, and severe in 42%. Patients with clinical dysarthria had greater lingual weakness than those without. As dysarthria severity increased, lingual strength decreased by an average of 6.82 kPa. Conclusions: These quantitative data provide additional evidence for presence of bulbar muscle disease in patients with LOPD. Further study is necessary to determine functional effects, temporal progression, and effects of treatment. Muscle Nerve 51:731–735, 2015

[1]  Berthold Kiefer,et al.  Liver fat quantification using a multi‐step adaptive fitting approach with multi‐echo GRE imaging , 2014, Magnetic resonance in medicine.

[2]  P. Barkhaus,et al.  Changes in Tongue Pressure, Pulmonary Function, and Salivary Flow in Patients with Amyotrophic Lateral Sclerosis , 2013, Dysphagia.

[3]  C. Lazarus,et al.  A Systematic Review and Meta-analysis of Measurements of Tongue and Hand Strength and Endurance Using the Iowa Oral Performance Instrument (IOPI) , 2013, Dysphagia.

[4]  A. Pestronk,et al.  Open-label extension study following the Late-Onset Treatment Study (LOTS) of alglucosidase alfa. , 2012, Molecular genetics and metabolism.

[5]  P. Kishnani,et al.  Expanding the phenotype of late‐onset pompe disease: Tongue weakness: A new clinical observation , 2011, Muscle & nerve.

[6]  D. Annane,et al.  Whole-body muscle MRI in 20 patients suffering from late onset Pompe disease: Involvement patterns , 2011, Neuromuscular Disorders.

[7]  L. Morrison,et al.  Swallow characteristics in patients with oculopharyngeal muscular dystrophy. , 2010, Journal of speech, language, and hearing research : JSLHR.

[8]  P. Kishnani,et al.  Language and speech function in children with infantile Pompe disease , 2009, Journal of Pediatric Neurology online.

[9]  R. Short,et al.  Maximal Tongue Strength in Typically Developing Children and Adolescents , 2009, Dysphagia.

[10]  H Nazirah,et al.  THE APPLICATIONS OF INTERNATIONAL CLASSIFICATION OF FUNCTIONING, DISABILITY AND HEALTH (ICF) BY WORLD HEALTH ORGANIZATION(WHO) IN REHABILITATION MEDICINE PRACTICE , 2007 .

[11]  Claude Desnuelle,et al.  Development of a French isometric strength normative database for adults using quantitative muscle testing. , 2007, Archives of physical medicine and rehabilitation.

[12]  J. Hogrel,et al.  Isokinetic muscle testing for weak patients suffering from neuromuscular disorders: A reliability study , 2007, Neuromuscular Disorders.

[13]  David M. Rapoport,et al.  Pompe disease diagnosis and management guideline , 2006, Genetics in Medicine.

[14]  K. Felice,et al.  Clinical Variability in Adult‐Onset Acid Maltase Deficiency: Report of Affected Sibs and Review of the Literature , 1995, Medicine.

[15]  J. Duffy Motor Speech Disorders: Substrates, Differential Diagnosis, and Management , 1995 .

[16]  M. Margolis,et al.  Obstructive sleep apnea syndrome in acid maltase deficiency. , 1994, Chest.

[17]  J. D. van der Walt,et al.  The pattern of involvement of adult‐onset acid maltase deficiency at autopsy , 1987, Muscle & nerve.

[18]  P. Hudgson,et al.  Adult myopathy from glycogen storage disease due to acid maltase deficiency. , 1968, Brain : a journal of neurology.

[19]  F. Glocker,et al.  Enzyme replacement therapy with alglucosidase alfa in 44 patients with late-onset glycogen storage disease type 2: 12-month results of an observational clinical trial , 2009, Journal of Neurology.

[20]  Kathryn M. Yorkston,et al.  Management of motor speech discorders in children and adults , 1999 .